Computer tech company Oracle has teamed up with the National Institutes of Health (NIH) to develop a cloud-based volunteer screening registry — the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry — to support COVID-19-related clinical trials. Oracle registered more than 100,000 people in the registry within a week of going live. Read More
A COVID-19 rapid response plan that helped one pharma company restart all of its paused studies worldwide by mid-July can serve as a model for other drugmakers trying to recover from the pandemic. Read More
The Department of Justice announced last week that two Chinese hackers have been indicted on charges of trying to hack COVID-19 vaccine research in the U.S. Read More
Sites that rarely, if ever, conducted virtual patient visits via phone or video prior to the pandemic have been convinced of the value of the technology for clinical trials in the future. Read More
Site staff believe more telecommunication technology will be needed to get trials back on their feet post-pandemic and say they need help from sponsors and CROs to implement alternative approaches to in-person patient visits, according to a new report. Read More
In an open letter to the National Institutes of Health (NIH), more than 125 of the world’s top scientists have called on the U.S. government to start conducting human challenge trials to accelerate COVID-19 vaccine development. Read More
As research on COVID-19 vaccines advances at an unprecedented pace, Russian hackers have been attempting to steal research information, the UK’s National Cyber Security Centre (NCSC) reported last week. Read More
The FDA said last week that it has reviewed more than 230 clinical trials of potential COVID-19 treatments so far through its Coronavirus Treatment Acceleration Program (CTAP). Read More